Valuation: Eckert & Ziegler SE

Market Cap 773M 870M 721M 657M 1.24B 83.62B 1.25B 8.73B 3.38B 42.75B 3.27B 3.19B 137B P/E 2026 *
15.1x
P/E 2027 * 14.3x
Enterprise Value 657M 740M 613M 559M 1.05B 71.09B 1.06B 7.42B 2.88B 36.34B 2.78B 2.72B 117B EV / Sales 2026 *
2.07x
EV / Sales 2027 * 1.9x
Free-Float
67.36%
Yield 2026 *
1.7%
Yield 2027 * 1.74%
1 day-9.48%
1 month-9.48%
3 months-18.42%
1 month 11.82
Extreme 11.824
11.85
Current year 11.82
Extreme 11.824
14.67
1 year 11.82
Extreme 11.824
14.67
3 years 11.82
Extreme 11.824
14.67
5 years 11.82
Extreme 11.824
14.67
10 years 11.82
Extreme 11.824
14.67
Manager TitleAgeSince
Chief Executive Officer 59 07/06/2023
Chief Tech/Sci/R&D Officer - 01/01/2025
Chief Operating Officer 59 01/01/2025
Director TitleAgeSince
Director/Board Member 73 01/01/2019
Chairman 57 07/06/2023
Director/Board Member 66 01/01/2014
Change 5-day change 1-year change 3-year change Capi.($)
-9.48%-.--% - - 870M
+0.35%-2.99%+24.73%+32.07% 242B
+1.09%-4.65%+1.77%+0.15% 150B
-2.32%-3.27%-11.53%+32.87% 138B
-1.46%-3.01%-55.73%-19.33% 61.74B
-0.05%-1.32%+11.09%+23.08% 49.08B
+0.66%+0.19%-19.29%-21.24% 47.43B
+0.66%-2.90%+20.97%+51.29% 47.3B
-3.05%-2.62%-9.13%+35.86% 44.25B
-0.08%-1.92%+32.09%+57.18% 41.78B
Average -1.11%-2.50%-0.56%+21.33% 91.4B
Weighted average by Cap. +0.14%-3.27%+3.37%+21.48%

Financials

2026 *2027 *
Net sales 318M 358M 297M 271M 510M 34.4B 515M 3.59B 1.39B 17.59B 1.34B 1.31B 56.45B 342M 385M 319M 291M 548M 36.98B 554M 3.86B 1.5B 18.91B 1.44B 1.41B 60.68B
Net income 51.68M 58.17M 48.23M 43.96M 82.92M 5.59B 83.69M 584M 226M 2.86B 218M 214M 9.17B 53.08M 59.75M 49.55M 45.16M 85.17M 5.74B 85.96M 600M 232M 2.94B 224M 219M 9.42B
Net Debt -116M -130M -108M -98.48M -186M -12.53B -187M -1.31B -507M -6.4B -489M -479M -20.55B -123M -138M -114M -104M -197M -13.25B -198M -1.38B -536M -6.78B -518M -506M -21.75B
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,105
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.35EUR
Average target price
21.60EUR
Spread / Average Target
+74.90%

Annual profits - Rate of surprise